Issued Patents All Time
Showing 26–50 of 51 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10526417 | Heterodimeric antibodies that bind CD3 and CD38 | Matthew Bernett, Gregory Moore, John Desjarlais, Rumana Rashid, Umesh Muchhal | 2020-01-07 |
| 10519242 | Targeting regulatory T cells with heterodimeric proteins | Matthew Bernett, Dilki Wickramarachchi, John Desjarlais | 2019-12-31 |
| 10428155 | Trispecific antibodies | Gregory Moore, John Desjarlais, Sung-Hyung Lee | 2019-10-01 |
| 10259887 | Heterodimeric antibodies that bind CD3 and tumor antigens | Matthew Bernett, Gregory Moore, John Desjarlais, Rumana Rashid, Umesh Muchhal +1 more | 2019-04-16 |
| 10227411 | Modulation of T cells with bispecific antibodies and FC fusions | Matthew Bernett, Dilki Wickramarachichi, John Desjarlais | 2019-03-12 |
| 10227410 | Heterodimeric antibodies that bind CD3 and PSMA | Gregory Moore, John Desjarlais | 2019-03-12 |
| 9914778 | Methods and compositions for inhibiting CD32B expressing cells | John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Gregory Moore, Igor Vostiar | 2018-03-13 |
| 9902773 | Methods and compositions for inhibiting CD32b expressing cells | John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Gregory Moore, Igor Vostiar | 2018-02-27 |
| 9856327 | Heterodimeric antibodies to CD3 X CD123 | Matthew Bernett, Gregory Moore, John Desjarlais, Rumana Rashid, Umesh Muchhal +1 more | 2018-01-02 |
| 9850320 | Heterodimeric antibodies to CD3 X CD20 | Matthew Bernett, Gregory Moore, John Desjarlais, Rumana Rashid, Umesh Muchhal +1 more | 2017-12-26 |
| 9822186 | Bispecific antibodies that bind to CD38 and CD3 | Matthew Bernett, Gregory Moore, John Desjarlais | 2017-11-21 |
| 9803020 | Optimized antibodies that target CD19 | Matthew Bernett, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Erik Weiking Pong +2 more | 2017-10-31 |
| 9617348 | Compositions and methods for treating IgE-mediated disorders | John Desjarlais, Holly M. Horton, Matthew Bernett | 2017-04-11 |
| 9574006 | Optimized anti-CD30 antibodies | Gregory Alan Lazar, John Desjarlais, Philip W. Hammond, David F. Carmichael, Bao-Lu Chen +2 more | 2017-02-21 |
| 9540451 | Compositions and methods for treating IgE-mediated disorders | John Desjarlais, Holly M. Horton, Matthew Bernett | 2017-01-10 |
| 9394366 | Methods and compositions for inhibiting CD32B expressing cells | John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Gregory Moore, Igor Vostiar | 2016-07-19 |
| 9266966 | Compositions and methods for treating IgE-mediated disorders | John Desjarlais, Holly M. Horton, Matthew Bernett | 2016-02-23 |
| 9260523 | Methods and compositions for inhibiting CD32b expressing cells | John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Gregory Moore, Igor Vostiar | 2016-02-16 |
| 9221916 | Compositions and methods for treating IgE-mediated disorders | John Desjarlais, Holly M. Horton, Matthew Bernett | 2015-12-29 |
| 9079960 | Methods and compositions for inhibiting CD32B expressing cells | John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Gregory Moore, Igor Vostiar | 2015-07-14 |
| 9062117 | Compositions and methods for treating IgE-mediated disorders | John Desjarlais, Holly M. Horton, Matthew Bernett | 2015-06-23 |
| 8551485 | Anti-CD40 antibodies and methods of inhibiting proliferation of CD40 expressing cells | Matthew Bernett, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Erik Weiking Pong +1 more | 2013-10-08 |
| 8524867 | Optimized antibodies that target CD19 | Matthew Bernett, John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Erik Weiking Pong +2 more | 2013-09-03 |
| 8435517 | Compositions and methods for treating IgE-mediated disorders | John Desjarlais, Holly M. Horton, Matthew Bernett | 2013-05-07 |
| 8063187 | Methods and compositions for inhibiting CD32B expressing cells | John Desjarlais, Sher Bahadur Karki, Gregory Alan Lazar, Gregory Moore, Igor Vostiar | 2011-11-22 |